Citations (33)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Ioanna Tsiligianni, Kristian Jong Hoeines, Christian Jensen, Janwillem W H Kocks, Björn Ställberg, Claudia Vicente & Rudi Peché. (2021) Towards Rational Prescription of Common Inhaler Medication in the Multimorbid COPD Patient. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 1315-1327.
Read now
Read now
Shahla Shojaei, Madhumita Suresh, Daniel J. Klionsky, Hagar Ibrahim Labouta & Saeid Ghavami. (2020) Autophagy and SARS-CoV-2 infection: A possible smart targeting of the autophagy pathway. Virulence 11:1, pages 805-810.
Read now
Read now
Indumathi Kumarathas, Torben Harsløf, Charlotte Uggerhøj Andersen, Bente Langdahl, Ole Hilberg, Leif Bjermer & Anders Løkke. (2020) The risk of osteoporosis in patients with asthma. European Clinical Respiratory Journal 7:1.
Read now
Read now
Paola Rogliani, Vito Brusasco, Leonardo Fabbri, Andrea Ungar, Elisa Muscianisi, Ilaria Barisone, Alberto Corsini & Giuseppe De Angelis. (2018) Multidimensional approach for the proper management of a complex chronic patient with chronic obstructive pulmonary disease. Expert Review of Respiratory Medicine 12:2, pages 103-112.
Read now
Read now
Javier de Miguel-Diez, Rodrigo Jiménez-García, Valentin Hernández-Barrera, Pilar Carrasco-Garrido, Luis Puente-Maestu, Laura Ramírez García & Ana Lopez de Andres. (2016) Is COPD a Risk Factor for Hip Fracture?. COPD: Journal of Chronic Obstructive Pulmonary Disease 13:6, pages 779-789.
Read now
Read now
Pamela Spencer & Nicola A Hanania. (2013) Optimizing safety of COPD treatments: role of the nurse practitioner. Journal of Multidisciplinary Healthcare 6, pages 53-63.
Read now
Read now
Articles from other publishers (27)
Ziyan Wang, Yang Liu, Jianing Zhang, Minmin Lin, Chufan Xiao, Haoying Bai & Chao Liu. (2021) Mechanical loading alleviated the inhibition of β2‐adrenergic receptor agonist terbutaline on bone regeneration. The FASEB Journal 35:12.
Crossref
Crossref
Saman Sargazi, Roghayeh Sheervalilou, Mohsen Rokni, Milad Shirvaliloo, Omolbanin Shahraki & Nima Rezaei. (2021) The role of autophagy in controlling SARS‐CoV‐2 infection: An overview on virophagy‐mediated molecular drug targets. Cell Biology International 45:8, pages 1599-1612.
Crossref
Crossref
Mariano Mollica, Luigi Aronne, Giorgio Paoli, Martina Flora, Grazia Mazzeo, Stefania Tartaglione, Rita Polito, Carmelindo Tranfa, Maria Ceparano, Klara Komici, Gennaro Mazzarella & Carlo Iadevaia. (2020) Elderly with COPD: comoborbitidies and systemic consequences. Journal of Gerontology and Geriatrics 69:1, pages 32-44.
Crossref
Crossref
Christophe Gut-Gobert, Arnaud Cavaillès, Adrien Dixmier, Stéphanie Guillot, Stéphane Jouneau, Christophe Leroyer, Sylvain Marchand-Adam, David Marquette, Jean-Claude Meurice, Nicolas Desvigne, Hugues Morel, Christine Person-Tacnet & Chantal Raherison. (2019) Women and COPD: do we need more evidence?. European Respiratory Review 28:151, pages 180055.
Crossref
Crossref
Ji-Yong Moon & Don D. Sin. (2019) Inhaled corticosteroids and fractures in chronic obstructive pulmonary disease. Current Opinion in Pulmonary Medicine 25:2, pages 165-172.
Crossref
Crossref
Chun-Hao Tsai, Lin-Yu Liao, Cheng-Li Lin & Wei-Sheng Chung. (2018) Inhaled corticosteroids and the risks of low-energy fractures in patients with chronic airway diseases: A propensity score matched study. The Clinical Respiratory Journal 12:5, pages 1830-1837.
Crossref
Crossref
Ioanna Tsiligianni, Miguel Román Rodríguez, Karin Lisspers, Tze LeeTan & Antonio Infantino. (2017) Call to action: improving primary care for women with COPD. npj Primary Care Respiratory Medicine 27:1.
Crossref
Crossref
Angela K. Beckert & Edmund H. Duthie. (2016) The Wrath of Steroids in Elderly Patients with Pulmonary Diseases. Current Geriatrics Reports 5:2, pages 124-131.
Crossref
Crossref
S.-J. Chen, W.-C. Liao, K.-H. Huang, C.-L. Lin, W.-C. Tsai, P.-T. Kung, K.-H. Chang & C.-H. Kao. (2015) Chronic obstructive pulmonary disease and allied conditions is a strong independent risk factor for osteoporosis and pathologic fractures: a population-based cohort study. QJM 108:8, pages 633-640.
Crossref
Crossref
Eleanor Warwick, Andrew Scourfield & Jennifer Quint. (2015) Systemic manifestations of chronic obstructive pulmonary disease. British Journal of Hospital Medicine 76:6, pages 324-329.
Crossref
Crossref
Malay SarkarRajeev BhardwajIrappa MadabhaviJasmin Khatana. (2015) Osteoporosis in Chronic Obstructive Pulmonary Disease. Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine 9, pages CCRPM.S22803.
Crossref
Crossref
Gourab Choudhury, Roberto Rabinovich & William MacNee. (2014) Comorbidities and Systemic Effects of Chronic Obstructive Pulmonary Disease. Clinics in Chest Medicine 35:1, pages 101-130.
Crossref
Crossref
Bente Morseth, Hasse Melbye, Svanhild Waterloo, Marte R Thomassen, Marijke J Risberg & Nina Emaus. (2013) Cross-sectional associations between prevalent vertebral fracture and pulmonary function in the sixth Tromsø study. BMC Geriatrics 13:1.
Crossref
Crossref
James F. Donohue & Neal Jain. (2013) Exhaled nitric oxide to predict corticosteroid responsiveness and reduce asthma exacerbation rates. Respiratory Medicine 107:7, pages 943-952.
Crossref
Crossref
Kavitha Nadesalingam & David Kirby. (2013) Bone protection in chronic obstructive pulmonary disease (COPD) patients requiring regular intermittent glucocorticoid therapy.. Clinical Medicine 13:2, pages 216-216.
Crossref
Crossref
David Price, Barbara Yawn, Guy Brusselle & Andrea Rossi. (2012) Risk-to-benefit ratio of inhaled corticosteroids in patients with COPD. Primary Care Respiratory Journal 22:1, pages 92-100.
Crossref
Crossref
José Luis Izquierdo Alonso & José Miguel Rodríguez Glez-Moro. (2012) Utilización excesiva de corticoides inhalados en la enfermedad pulmonar obstructiva crónica. Archivos de Bronconeumología 48:6, pages 207-212.
Crossref
Crossref
José Luis Izquierdo Alonso & José Miguel Rodríguez Glez-Moro. (2012) The Excessive Use of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease. Archivos de Bronconeumología (English Edition) 48:6, pages 207-212.
Crossref
Crossref
Namgyal L. Kyulo, Synnove F. Knutsen, Gary E. Fraser & Pramil N. Singh. (2012) Effect of Weight Loss in Adults on Estimation of Risk Due to Adiposity in a Cohort Study. Obesity 20:1, pages 206-213.
Crossref
Crossref
Luis F. Diez-Morales & Vincent Cunanan. 2012. Chronic Obstructive Pulmonary Disease. Chronic Obstructive Pulmonary Disease
61
68
.
Raj Mitra. (2011) Adverse Effects of Corticosteroids on Bone Metabolism: A Review. PM&R 3:5, pages 466-471.
Crossref
Crossref
An Lehouck, Steven Boonen, Marc Decramer & Wim Janssens. (2011) COPD, Bone Metabolism, and Osteoporosis. Chest 139:3, pages 648-657.
Crossref
Crossref
A. Lehouck, H. van Remoortel, T. Troosters, M. Decramer & W. Janssens. (2010) BPCO et métabolisme osseux: une mise à jour clinique. Revue des Maladies Respiratoires 27:10, pages 1231-1242.
Crossref
Crossref
S. Gonnelli, C. Caffarelli, S. Maggi, G. Guglielmi, P. Siviero, S. Rossi, G. Crepaldi & R. Nuti. (2010) Effect of Inhaled Glucocorticoids and β2 Agonists on Vertebral Fracture Risk in COPD Patients: The EOLO Study. Calcified Tissue International 87:2, pages 137-143.
Crossref
Crossref
Alison Shepherd. (2010) The nutritional management of COPD: an overview. British Journal of Nursing 19:9, pages 559-562.
Crossref
Crossref
Adolfo Baloira. (2010) Triple terapia en el tratamiento de la EPOC. Archivos de Bronconeumología 46, pages 25-30.
Crossref
Crossref
Cristóbal Esteban & Myriam Aburto. (2010) Seguridad de los corticoides inhalados en la EPOC. Archivos de Bronconeumología 46, pages 28-35.
Crossref
Crossref